Madam Speaker, I am struck by two things with respect to this issue. The first is that we had a private member's bill that dealt with many similar issues which had already progressed through the committee stage. The government voted to kill that bill in favour of bringing forward a government bill that was different but in many ways similar. The Liberals complain about how in their view the Standing Orders do not provide them with enough ability to advance government legislation. If they actually considered the ideas that come through private members' business, maybe they would not have to go through the process of reintroducing some of the legislation, although with certain modifications that we certainly have concerns about.
The second is that in this legislation there is a presumption that the technology is there for impairment testing around marijuana and that it is somehow analogous to alcohol in terms of the relative ease of impairment testing. The reality is that these are different substances with different kinds of impacts. Marijuana is fat-soluble, which means it is retained in the brain, even if it is much less present in other bodily fluids from a testing perspective. This creates major concerns when we establish a test through bodily fluids for determining impairment. There may be impairment, even if it is not showing up in high levels of bodily fluid, but it may show up in higher levels in those fluids when there is not as much impairment.
I wonder if the member can comment on these two major problems with the way the government is proceeding.